Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function

Journal of Clinical Investigation

Volumn 100, Issue 12, 1997, Pages 3005-3013

  Large, Valérie ^a   Hellström, Lena ^a   Reynisdottir, Signy ^a   Lönnqvist, Fredrik ^a   Eriksson, Per ^a   Lannfelt, Lars ^a   Arner, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

DNA; Fat cell; Lipolysis; Polymerase chain reaction; Restriction fragment length polymorphism

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE;

ADIPOCYTE; ARTICLE; BODY FAT; BODY MASS; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; LIPOLYSIS; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT;

EID: 0031436966     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119854     Document Type: Article

References (30)

1. Bouchard, C. 1996. Long-term programming of body size. Nutr. Rev. 54: S8-S16.
2. Spiegelman, B.M., and J.S. Flier. 1996. Adipogenesis and obesity: rounding out the big picture. Cell. 87:377-389.
3. Bouchard, C., and L. Perusse. 1996. Current status of the human obesity gene map. Obesity Res. 4:81-90.
4. Lafontan, M., and M. Berlan. 1993. Fat cell adrenergic receptor and the control of white and brown fat cell function. J. Lipid Res. 34:1057-1091.
5. 3-adrenoceptor in man. J. Clin. Invest. 95:2239-2245.
6. Barbe, P., L. Millet, J. Galitzki, M. Lafontan, and M. Berlan. 1996. In situ assessment of the role of betal-, beta2-, and beta3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br. J. Pharmacol. 117:907-913.
7. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N. Engl. J. Med. 333:352-354.
8. 3-adrenergic-receptor gene. N. Engl. J. Med. 333:343-347.
9. 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N. Engl. J. Med. 333:348-351.
10. 3-adrenergic receptor gene affects basal metabolic rate in obese Finns. Diabetes. 46:77-80.
11. 3-adrenergic receptor gene has no effect on obesity phenotype in the Quebec family study and Swedish obese subjects cohort. J. Clin. Invest. 98:2086-2093.
12. 3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia. 39:349-352.
13. Li, L.S., F. Lönnqvist, H, Luthman, and P. Arner. 1996. Phenotypic characterization of the Trp64Arg polymorphism in the beta3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia. 39:857-860.
14. Candelore, M.R., L. Deng, L.M. Tota, L.J. Kelly, M.A. Cascieri, and C.D. Strader. 1996. Pharmacological characterization of a recently described human beta 3-adrenergic receptor mutant. Endocrinology. 137:2638-2641.
15. 2-adrenergic receptor structure. Pharm. Pharmacol. 8:1-10.
16. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry. 33:9414-9439.
17. 3-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J. Biol. Chem. 268:23116-23121.
18. 2-adrenergic receptor variants in asthma. Clin. Exp. Allergy. 25:89-94.
19. 2-adrenergic receptor in nocturnal and nonnocturnal asthma. J. Clin. Invest. 95:1635-1641.
20. Large, V., S. Reynisdottir, L. Eleborg, V. van Harmelen, L. Strömmer, and P. Arner. 1997. Lipolysis in human fat cells obtained under local and general anesthesia. Int. J. Obesity. 21:78-82.
21. Gallagher, D., M. Visser, D. Sepulveda, N. Pierson, T. Harris, and S.B. Heymsfield. 1995. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups. Am. J. Epidemiol. 143:228-239.
22. Reynisdottir, S., K. Ellerfeldt, H. Wahrenberg, H. Lithell, and P. Arner. 1994. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. J. Clin. Invest. 93:2590-2599.
23. Hellmer, J., P. Arner, and A. Lundin. 1989. Automatic luminometric kinetic assay of glycerol for lipolysis studies. Anal. Biochem. 177:132-137.
24. Kenakin, T. 1984. The classification of drugs and drug receptors in isolated tissue. Pharmacol. Rev. 36:165-214.
25. Ott, J. 1991. Analysis of Human Genetic Linkage. The Johns Hopkins University Press. Baltimore and London. 240-241.
26. Arner, P., J. Hellmer, A. Wennlund, J. Östman, and P. Engfeldt. 1988. Adrenoceptor occupancy in isolated human fat cells and its relationship with Iipolysis rate. Eur. J. Pharmacol. 146:45-56.
27. 2-adrenergic receptor in normal and asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 8:334-339.
28. 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for plalelet-derived growth factor. Proc. Natl. Acad. Sci. USA. 84:46-50.
29. Streamson, C., and R.L. Leibel. 1997. Obesity genes: molecular and metabolic mechanisms. Diabetes Rev. 5:2-7.
30. Comuzzie, A.G., J.E. Hixson, L. Almasy, B.D. Mitchell, M.C. Mahaney, T.D. Dyer, M.P. Stern, J.W. MacCluer, and J. Blangero. 1997. A major quantitative trait locus determining serum leptin levels and fat mass is located on chromosome 2. Nat. Genet. 15:273-276.